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Abstract 
 
Objectives This study aimed to explore experienced community and hospital 
pharmacists’ perceptions of how their pharmacy practice and status in health care are 
affected by others’ views of them.  
Methods A qualitative collective case study was conducted. The primary data were 
20 in-depth semistructured interviews of community and hospital pharmacists in 
England that were audio-recorded, transcribed and analysed thematically.  
Key findings Thematic analysis of the data identified four themes: (1) ambiguities 
about being professionals, (2) internal divisions, (3) medicines experts and (4) 
shopkeepers as healthcare providers.  
Conclusions Pharmacists want to be recognised as medicines experts in health care. 
They are aware that their status is assessed by the public based on their practice, 
which is dispensing of medicines, and that the public’s image of all pharmacists is that 
of ‘a typical community pharmacist’ working in a retail shop while having little 
experience of pharmacists in other healthcare settings. Pharmacists consider that the 
public does not view them as registered healthcare professionals. They mainly 
associate being registered professionals with being controlled from afar by their 
professional regulator, instead of utilising this as an enabling strategy to support their 
reprofessionalisation efforts. Pharmacists remain the hidden healthcare profession 
and need to act in practice as healthcare professionals, so the public is aware of their 
place and contributions in health care to maintain or enhance their status. Internal 
divisions between community and hospital pharmacists appear to be due to 
differences in practice, knowledge and aspirations having the potential to adversely 
affect the pharmacy profession’s status. 
 
Introduction  
 
Pharmacists’ status in health care has not been widely examined in the literature.[1–
5] The functionalist trait approach has been used to argue for or against pharmacy 
being described as a marginal profession, whereas Dingwall and Wilson maintain the 
importance of examining the ‘everyday work of pharmacists’ to assess their 
status.[2,6,7] Abbott dismisses the functionalist trait approach due to inadequate 
theoretical rationale to support it.[2,8,9] Abbott draws attention to the work professions 
do and how they maintain jurisdictional control in the workplace, with jurisdiction being 
the link between a profession and its practice.[8] Jurisdiction is considered an area of 
work that a profession controls including defining best practice standards and has 
justifiable social claims and legitimate responses from the public and the State to 
these claims.[8,10] The State is the government including an ensemble of institutions 
collectively forming the direction it takes enabling it to govern.[11] Status is associated 
with a profession’s practice and is considered a lasting and general strategy for 
professions.[10,12]  
 
Professionalisation comprises dynamic and continuous social processes affecting a 
profession’s efforts to maintain, enhance or defend its status including control of 
jurisdiction.[8,10] Several external and internal factors facilitate (reprofessionalise) or 
hinder (deprofessionalise) these professionalisation processes.[8,13,14]  
 
Pharmacists have a peripheral role within health care.[5,15,16] National policy drivers 
aim to extend pharmacists’ practice beyond their jurisdiction of dispensing into clinical 
patient-centred roles, as with increasing healthcare needs, pharmacy is seen as an 
underutilised resource.[17–20] In England, this includes pharmacists gaining 
prescribing rights, establishing consultant pharmacist roles and working for general 
practitioners.[21–25] Despite these initiatives, the Nuffield Report, 2014, ‘Now more 
than ever: Why pharmacy needs to act’ concludes there has been limited 
development of pharmacists’ jurisdiction over the previous few decades.[26,27] The 
State, other stakeholders and the public lack understanding of what pharmacists do 
and can do in health care.[20,26]  
 
The undergraduate degree for pharmacists in Great Britain is a 4-year Master of 
Pharmacy course followed by a preregistration year concluding with a registration 
examination set by the General Pharmaceutical Council, the statutory professional 
regulator for pharmacists. There are two main sectors in pharmacy: community and 
hospital. Just over 70% of pharmacists work in community pharmacy and about a 
quarter in hospital pharmacy.[28] In England, community pharmacies are privately 
owned businesses contracted to deliver publicly funded pharmaceutical services 
within the National Health Service (NHS), mainly dispensing with some limited non-
dispensing pharmaceutical services which are gradually increasing.[29] Hospital 
pharmacists are employed by the NHS. For decades, they have delivered non-
dispensing clinical pharmaceutical services, working on inpatient wards and having 
access to patients’ medical notes and blood tests results.[30]  
 
Existing studies have concentrated on community pharmacists (CP), and few have 
included hospital pharmacists.[1,3] This study aimed to explore experienced 
community and hospital pharmacists’ perceptions of how their pharmacy practice and 
status in health care are affected by others’ views of them. 
 
 
 
Methods  
 
Qualitative collective case study methodology was used within a constructivist enquiry 
emphasising pharmacists’ perceptions which consisted of four case studies.[31–33] 
Each case study included five pharmacists representing a healthcare setting: 
community pharmacy, acute hospital, mental health and community health services, 
respectively. The latter three are public NHS organisations.  
 
The sample size of 20 pharmacists was based on what was considered to be large 
enough to provide enough breadth and small enough so as not to lose much 
depth.[32] The sampling was purposive, a non-random method, to gain insight into 
pharmacists’ perceptions.[34] The entry criteria were that pharmacists had been 
registered for at least 5 years, worked in the relevant healthcare setting for 2 years or 
more and provided written informed consent. Pharmacists from researcher IA’s NHS 
workplace were excluded.  
 
Community pharmacists on the university’s student practice placement list were 
invited to participate. Acute hospital (AHP), mental health (MHP) and community 
health services (CHSP) pharmacists, collectively referred to as ‘hospital pharmacists’, 
were emailed by their chief pharmacist with information about the study and an 
invitation to contact IA. It was unknown how many hospital pharmacists were emailed.  
 
A single face-to-face semistructured interview was used to solicit each pharmacist’s 
perceptions about how they viewed their practice, contributions made, the future and 
how others viewed them. Pharmacists completed a 5-day diary recording positive 
contributions or frustrations experienced to obtain data in real time.  
 
Pharmacists were emailed the study information sheet and consent form in advance 
of the semistructured interview and asked to agree to it being voice-recorded, 
otherwise notes were taken. Arrangements were made for the semistructured 
interview to take place at pharmacists’ workplace or university.  
 
The semistructured interviews and transcriptions were undertaken by IA, who also 
took notes to capture reflections throughout the research process.[32,35] The data for 
each case study were analysed using inductive thematic analysis followed by the 
cross-case analysis.[36–38] This was an iterative process, which included going back 
and forth between the individual cases and the cross-case analysis.[37]  
 
Emerging themes were discussed with PM and PG. The findings were shared in 2016 
with two peer groups: one included 12 CP and the second 15 pharmacists and five 
pharmacy technicians from acute hospital, mental health, community health services 
and community pharmacy. This was to give the findings credibility and check they 
resonated with them, which they did.[36]  
The University Research Ethics and Governance Committee approved the study 12 
March 2012. NHS research and governance approvals were obtained between 18 
April and 18 July 2012 from five NHS organisations. 
 
Results 
 
Twenty pharmacists (five in each case) from the South of England, who all fulfilled the 
entry criteria came forward, provided written informed consent and were interviewed. 
On average, pharmacists had been registered for 21 (range: 5–37) years and had 
worked in their current healthcare setting for 13 (range: 2.5–27) years. All CP were 
employees.  
 
All semistructured interviews were undertaken at pharmacists’ workplaces, university 
and one at IA’s NHS workplace on request. They were voice-recorded, except for one 
pharmacist who asked for this not to be voicerecorded. The average interview took 
53 (range: 36–67) minutes. Fifteen diaries were returned by post covering all 
healthcare settings.  
 
The data analysis generated four themes (1) ambiguities about being professionals, 
(2) internal divisions, (3) medicines experts and (4) shopkeepers as healthcare 
providers. 
 
Ambiguities about being professionals  
 
Pharmacists were busy practitioners. They did not actively engage with what it meant 
to be professionals.  
 
I have never thought about it (AHP3).  
 
Pharmacists associated being a professional with conforming to regulations, 
displaying certain behaviours and being registered with their regulator. They 
questioned whether being registered equated to being a professional having observed 
that when pharmacy technicians became registered their behaviour did not alter. 
Pharmacists emphasised the negative aspects of being registered such as being 
reported to their regulator, having sanctions imposed or ‘being struck off’ (CHSP1) 
and this made public.  
 
Pharmacists believed they were answerable for their behaviour and conduct ‘whether 
in work or outside work’ (CP3).  
 
Pharmacists used terms such as ‘shopkeepers’ and ‘sticking labels on boxes’ to 
describe images others had of them. They explained that the public viewed all 
pharmacists as CP. Patients were surprised to see pharmacists on hospital wards.  
 
Patients turn around and say; ‘Oh I didn’t know they had pharmacists in 
hospitals (CHSP1).  
 
Pharmacists felt other healthcare professionals and patients believed their practice 
was ‘just dispensing’ (CHSP1), because it was this aspect that ‘is most important to 
them’ (MHP5) regardless of the healthcare setting.  
 
Pharmacists did not think the public viewed them as registered healthcare 
professionals.  
 
I do not think that pharmacy itself is particularly perceived as a profession by 
the general public (CP1) 
 
Internal divisions  
 
Hospital pharmacists viewed themselves as clinical, and CP as dispensers. Hospital 
pharmacists were in the process of handing over control of the dispensary to 
pharmacy technicians allowing them to develop their ‘expertise differently’ (AHP1). 
Hospital pharmacists had limited solidarity with CP who were not working to the 
professional standards they expected, reflecting adversely on the whole profession.  
 
I get really furious with that because that is my profession (CHSP2).  
 
Hospital pharmacists felt CP did not see ‘further than their dispensing role’ (MHP5), 
with no ambition to elevate the profession.  
 
Community pharmacists had difficulties in rising above their workload to develop their 
practice due to ‘increasing scripts [prescriptions] figures’ (CP5). 
 
Differences in practice, knowledge and aspirations resulted in divisions between 
hospital and CP, to the point where they considered them to be two different 
professions.  
 
They are almost distinct professions. Community pharmacy is completely 
different to hospital pharmacy (MHP3).  
 
There was no or limited collaboration or communication between pharmacists across 
the different healthcare settings in a systematic and consistent manner related to 
patient care. 
 
Medicines experts  
 
Pharmacists articulated the importance of being recognised as medicines experts 
because they have ‘a set of skills nobody else possesses’ (CP4). This allowed them 
to be ‘proud of what you do and who you are’ (AHP4). They linked this to their 
professional status, ‘that means you should be able to be a bit more of a pillar of 
society’ (AHP4).  
 
Hospital pharmacists continually increased their clinical knowledge including 
completing postgraduate courses working in a professional environment that 
facilitated this. They aspired to be recognised as specialists including having ‘as much 
knowledge as certainly a [medical] registrar or consultant’ (AHP2) and could progress 
from junior to chief pharmacist. Community pharmacists did not have similar 
aspirations, having limited access to postgraduate education and training while 
working as isolated practitioners making it ‘difficult to judge your own performance’ 
(CP1). They had no career progression. 
 
Pharmacists were frustrated if their advice was not considered by others or when 
other healthcare professionals claimed to be medicines experts (e.g. nurses) as this 
questioned their integrity. 
 
Everyone thinks they are an expert in medicines when they are not (CHSP 4). 
 
Shopkeepers as healthcare providers  
 
Community pharmacists balanced two conflicting roles as pharmacists and business 
managers explaining that they were ‘two separate things as much as the two collide’ 
(CP2). They were aware of the contradictory images of community pharmacy as a 
retail shop versus a place where health care was delivered contributing to the 
uncertainty of their role in health care. They reinforced the retail aspects by referring 
to ‘the shop’ during the study interviews.  
 
People do not understand, are we part of the NHS or are we a shop? (CP1).  
 
They avoided tackling certain health care and lifestyle matters with patients as they 
operated within a business ethos of customers ‘always being right’ and felt the retail 
environment was not always conducive to do this.  
Tackle people’s weight with them is unrealistic if you wish to have good 
customer relations. The pharmacy is not a place for that (CP1).  
 
Regulations placed them in situations between trying to satisfy their customers’ 
requests for over-the-counter medicines and their own judgement as they found it 
difficult to challenge customers’ choices to maintain good customer relations.  
 
They felt it was demeaning having to contact prescribers to substitute a prescribed 
medicine to another generic medicine which prevented them from using their own 
judgement.  
 
For CP working in a retail environment, having to achieve targets for pharmaceutical 
services and being constrained by medicines regulations adversely affected their 
autonomy and judgement introducing an element of disempowerment. 
 
Discussion  
 
Community and hospital pharmacists were aware that the public had one uniform 
image of them as a ‘typical community pharmacist’ dispensing medicines in retail 
shops while having limited experience of pharmacists in other contexts. Community 
and hospital pharmacists emphasised their differences. This is congruent with 
Abbott’s theory that the public has a narrow view of a profession which does not take 
account of intraprofessional differences and that a profession’s status is assessed by 
the public based on its act or nature of practice.[8,10]  
 
Images of pharmacists as ‘shopkeepers’ and ‘sticking labels on boxes’ are not 
associated with health care nor with special knowledge or skills.[39–41] Pharmacists 
felt the public did not view them as registered healthcare professionals. They 
reinforced this by focusing on the controlling aspects of being registered instead of 
utilising this to improve their status and ownership of an area of expertise to support 
new jurisdictional claims. Other authors have made similar findings arguing that being 
registered can be regarded as a tool for the State, via the regulator, of exercising 
control and influence over professionals with limited cost implications as they 
themselves meet the cost of being registered.[42,43] The State utilises being 
registered as leverage to influence, control and facilitate professional change, 
although professions and the State are not two opposing forces due to 
interdependencies.[44,45] The State mediates between pharmacy, patients and the 
public by determining what type of pharmaceutical services will receive funding.[11] 
To effectively bargain with the State and other stakeholders, the pharmacy profession 
needs to be united and corporately organised to maintain or enhance its status.[11,46] 
 
 
Study strengths and limitations  
 
The strength of this study was that data collected were from community and hospital 
pharmacists with collective case study methodology facilitating identification of 
themes which may not otherwise be discovered, such as internal divisions within 
pharmacy. In qualitative research, the researcher is the primary instrument for data 
collection and analysis which adds subjectivity.[36] To ensure rigour and quality, 
researcher IA aimed to maintain transparency by being reflective and sense-checked 
the findings with two peer groups.[32,36] As well as exploring pharmacists’ status, the 
study addressed a gap in the literature by including hospital pharmacists. The findings 
were based on a small sample, recruited from one geographical area that cannot be 
generalised to the broader pharmacy workforce but provides new insights adding to 
existing knowledge on pharmacists’ status.[32,36] A limitation is that the study is 
based on interviews with pharmacists and did not include observations or other 
healthcare professionals, key stakeholders and patients.  
 
Intraprofessional divisions in pharmacy  
 
Hospital pharmacists are what Abbott describes as professional ‘purists’ because they 
have a career structure, work in a professional environment focusing on developing 
their clinical pharmacy knowledge while enjoying a higher level of pharmacy practice 
than CP resulting in greater intraprofessional status.[8] In contrast, CP are isolated 
practitioners, working in a retail environment, with no career structure, also being 
concerned with non-pharmaceutical issues and dealing with patients and the public. 
Hospital pharmacists have started to separate their clinical and dispensary functions. 
CP remain in the dispensary undertaking routine work with pressures to meet 
commercial targets, with limited time to provide non-dispensing pharmaceutical 
services.[47,48] They wish to maintain the status quo possibly due to an increasing 
workload and uncertainty over the long-term sustainability of nondispensing 
pharmaceutical services.[47] A profession that relies on the status quo will lose 
status.[11] There is a lack of ideological solidarity between community and hospital 
pharmacists.[12,46] Most professions have internal subdivisions that lead to 
intraprofessional divisions.[8,49] Diversity within a profession can result in 
intraprofessional changes and developments forming part of its reprofessionalisation 
efforts or can move it towards a split producing a deprofessionalisation effect.[49,50] 
Internal divisions are relevant in an international context.[18] The international 
pharmacy workforce predominately works in community pharmacy with a minority 
practising in hospitals.[19] Community pharmacies are mainly remunerated based on 
dispensing fees, with few financial incentives to deliver non-dispensing 
pharmaceutical services.[19,51] In parts of Europe, the Middle East and North 
America, hospital pharmacy is considered an almost separate profession with 
different and additional postgraduate educational requirements to take on the 
challenges of working within the hospital setting.[52–55] Internal divisions in 
pharmacy appear to be due to differences in knowledge, practice and aspirations 
resulting in different subgroups denoted by differences in approach to professional 
problem-setting (i.e. how problems are framed influencing how a subgroup thinks 
about solutions).[49,56]  
 
Internal divisions are often contained within a profession making it appear to outsiders 
as united.[8,11] The problem occurs when these internal divisions are visible at 
national level reducing a profession’s ability to bargain with the State affecting its 
reprofessionalisation efforts.[11,26,27,46] Larson speculates that professional 
socialisation fosters ideological solidarity and improves professional cohesion, which 
can be achieved in pharmacy through embedding a formal postgraduate clinical 
career pathway with additional relevant training that is represented in practice.[12,57] 
 
Implications for practice  
This study suggests that pharmacists should start to act in practice as healthcare 
professionals including taking social responsibility for appropriate medicines use in 
society.[8,18,58,59] This includes displaying professional unity and generating public 
demand for their non-dispensing pharmaceutical services to support them in 
influencing the State to legitimise these jurisdictional claims.[8]  
 
As long as pharmacists remain the hidden healthcare profession, they have little hope 
of making new jurisdictional claims to maintain or increase their status. The image of 
a retail shop continues to be a barrier for the public and pharmacists themselves in 
being viewed as healthcare professionals.[5,16,60,61] This in turn affects the 
pharmacy profession as the public bases its assessment of the whole profession on 
a ‘typical community pharmacist’.[8]  
 
Future studies  
 
Future research should explore how key stakeholders, the public and patients’ 
perceptions of pharmacy affect its practice and status. Research on intraprofessional 
divisions is warranted. 
 
Conclusion  
 
Pharmacists want to be recognised as medicines experts within health care. They 
acknowledge that their status is assessed by the public based on their act of practice, 
which is traditionally the dispensing of medicines, and that the public’s image of all 
pharmacists is that of ‘a typical community pharmacist’ working in a retail shop, having 
limited experience of pharmacists in other contexts. Pharmacists consider that the 
public does not view them as registered healthcare professionals. They reinforce this 
view by focusing on the controlling aspects of being registered instead of utilising this 
to improve their status and ownership of an area of expertise to support new 
jurisdictional claims. Internal divisions between community and hospital pharmacists 
appear to be due to differences in practice, knowledge and aspirations.  
 
Pharmacists remain the hidden healthcare profession. They need to act in practice as 
healthcare professionals so the public and wider society is aware of their contributions 
to health care. 
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